Efficient method to optimize antibodies using avian leukosis virus display and eukaryotic cells

Abstract

Antibody-based therapeutics have now had success in the clinic. The affinity and specificity of the antibody for the target ligand determines the specificity of therapeutic delivery and off-target side effects. The discovery and optimization of high-affinity antibodies to important therapeutic targets could be significantly improved by the availability of a robust, eukaryotic display technology comparable to phage display that would overcome the protein translation limitations of microorganisms. The use of eukaryotic cells would improve the diversity of the displayed antibodies that can be screened and optimized as well as more seamlessly transition into a large-scale mammalian expression system for clinical production. In this study, we demonstrate that the replication and polypeptide display characteristics of a eukaryotic retrovirus, avian leukosis virus (ALV), offers a robust, eukaryotic version of bacteriophage display. The binding affinity of a model single-chain Fv antibody was optimized by using ALV display, improving affinity >2,000-fold, from micromolar to picomolar levels. We believe ALV display provides an extension to antibody display on microorganisms and offers virus and cell display platforms in a eukaryotic expression system. ALV display should enable an improvement in the diversity of properly processed and functional antibody variants that can be screened and affinity-optimized to improve promising antibody candidates.antibody engineering | avian leukosis virus | protein display technology | antibody binding affinity | avian leukosis virus polypeptide display

Unlocking the efficiency of genomics laboratories with robotic liquid-handling

“…Be it in microbiology [59], synthetic biology [60][61][62], endocrinology [63], or genetics [58,[64][65][66], laboratory biologists are increasingly trusting automated liquid handling workstations to streamline their protocols. Genomics laboratories at prominent institutions have also already dipped their feet in liquid-handling automation, be it for gene expression, NGS, or third-generation sequencing for a number of diseases [67][68][69][70][71][72][73][74][75][76][77][78][79][80][81][82][83].…”

In VitroSelection of Cancer Cell-Specific Molecular Recognition Elements from Amino Acid Libraries

“…Human HEK-293T, T cells, and B cells have all been used to display scFv libraries [ 57 – 59 ]. Additionally, a novel variation of this type of library has used a eukaryotic retrovirus to infect mammalian cells with a scFv library for replication and display [ 60 ]. While these libraries are not commercially available, methods for constructing them are [ 61 ].…”

High efficiency CHO cell display-based antibody maturation

“…However, transfection of plasmids into mammalian cells is not very efficient, and it is impossible to construct a sufficiently large library in this way. One way to circumvent the problem is to use viruses that carry antibody genes to efficiently infect mammalian cells 8 ; another approach is to mutate antibody genes in cells by activation-induced cytidine deaminase (AID) 9,10 . However, in both ways mammalian cells often contain multiple antibody genes, making the identification of desired clones time-consuming.…”